CEO SUMMARY: Here is an independent commercial laboratory that shows sustained growth while it maintains profitable operations. One key strategy is the selective acquisition of laboratory business in small, profitable chunks. The sales price paid for Medilabs demonstrates how much decline has occurred to the value of clinical laboratories. DESPITE THE PROFIT SQUEEZE on commercial […]
Bio-Reference Labs Buys New York-Based Medilabs
Acquisition activity by this publicly traded laboratory helps sustain multi-year growth
- By Robert Michel
- > From the Volume V No. 5 - April 13, 1998 Issue
